Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Bromhexine Hydrochloride Injection

Approval Number

国药准字H20223720

Company再维药业（海南）有限公司

Registration Date

November 23, 2022

Drug Information

Generic Name

盐酸溴己新注射液

Dosage Form

注射剂

Strength

2ml:4mg

Drug Type

化学药品

Registration Date

November 23, 2022

Company Information

Applicant Company

Company Name再维药业（海南）有限公司

Company Address

海南省澄迈县老城镇高新技术产业示范区海南生态软件园沃克公园C8855幢四层B区

Manufacturing Company

Company Name成都市海通药业有限公司

Company Address

成都市海峡两岸科技产业开发园柳台大道222号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸溴己新注射液 - NMPA 批准文号 | MedPath